Oct 2026
Beyond Tumor Size, Toward Meaningful Patient Outcomes-Resisting RECIST.
This Viewpoint evaluates the present relevance of Response Evaluation Criteria in Solid Tumors (RECIST) as cancer therapeutics have evolved beyond cytotoxic chemotherapy in assessing treatment outcomes.
C. Nabhan, V. Subbiah
· JAMA Oncology · 0 citations